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ABSTRACT 1 
We report a case of an early type Ia endoleak after endovascular aneurysm 2 
repair (EVAR) of an abdominal aortic aneurysm by Ovation stentGraft implantation 3 
and spontaneously resolved without further reintervention.  4 
Patient present a conic aortic neck but EAVR was performed within the 5 
instruction for use proposed by manufactory. At completion angiography a low flow 6 
type Ia endoleak was present and lift untreated. Computed tomographic 7 
angiography (CTA) performed in 3rd postoperative day showed infolding of the two 8 
sealing rings. Patient was dismissed without further treatment. At 3-month follow-up 9 
the leak appeared spontaneously sealed with partial expansion of the two rings.  10 
 11 
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INTRODUCTION 1 
Nowadays endovascular repair (EVAR) for abdominal aortic aneurysms (AAA) has 2 
become the standard of practice, and a huge variety of endografts is now available to the 3 
Vascular Physicians1,2.  Among those, the Ovation StentGraft (Trivascular, Inc, Santa 4 
Rosa, CA, USA) offers the lowest profile (14F introducer sheath) of any commercially 5 
available endograft increasing the number of patients suitable for EVAR including those 6 
with smaller and tortuous common iliac arteries (CIAs)3,4. Currently, Ovation StentGraft is 7 
indicated for treatment of patients with AAA with a vascular morphology suitable for EVAR, 8 
including: adequate iliac/femoral access, proximal aortic landing zone (inner wall diameter 9 
between 16 and 30mm at 13mm below the lowest renal artery, and aortic angle of ≤60° if 10 
proximal neck is ≥10mm and ≤45° if proximal neck is <10mm), and distal iliac la nding zone 11 
(at least 10mm in length, and with an inner wall diameter from 8 to 20mm). 12 
This device has a technology characterized by two polymer-filled rings that conform 13 
to the perimeter of the aortic neck. Rings are designed to ensure the sealing of the 14 
endoprosthesis in order to reduce the risk of type Ia endoleak without the radial force of 15 
other prostheses on the market. Despite this, the risk of type Ia endoleak due to 16 
inadequate sealing of the endograft leading to sac repressurization and enlargement, with 17 
a subsequent risk of wall rupture and death, is still present5,6,7,8, although rare9,10. In all 18 
reported experiences, type Ia endoleaks has required reintervention or endograft 19 
removal5,6,7,8. 20 
We report a case of spontaneous sealing of a type Ia endoleak after deployment of 21 
an Ovation stentgraft in a patient with on-label aortic neck anatomy. 22 
 23 
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CASE REPORT 1 
A 75-year-old man was admitted to our Unit for an asymptomatic AAA detected by 2 
duplex ultrasound scan (DUS). His medical history was significant for smoking, 3 
hypertension, hypercholesterolemia and previous laparoscopic cholecystectomy. On 4 
physical examination a pulsatile epigastric mass was evident; femoral and distal pulses 5 
were normally present on both sides. 6 
Computed tomographic angiography (CTA) confirmed the presence of a saccular 7 
infrarenal AAA not extending above the aortic carrefour (maximum transversal diameter 8 
45mm) with a huge amount of intraluminal thrombus and a short, conical proximal neck 9 
(Fig.1). Iliac axes and common femoral arteries were patent without stenosis, dilatation, 10 
and severe angulation. 11 
EVAR procedure was planned using a non conventional endograft (Ovation 12 
StentGraft) to achieve a good proximal sealing. According to standard preoperative 13 
planning for Ovation3, diameters of the aorta were assessed at infrarenal (IR) level 14 
19.6mm, IR-35 23.1mm, IR+13 28mm and IR+16 30.7mm. 15 
Endovascular procedure was performed by Vascular Surgeons in an operating 16 
theatre equipped with a portable fluoroscopy unit (Euroamplin Alien, Eurocolumbus – 17 
Milan, Italy), under local anaesthesia via percutaneous access to common femoral artery 18 
at both groins. 19 
Subsequently to femoral access, the tri-modular stent graft was delivered and 20 
deployed in three stages: unsheathing the 34mm main body, deploying the suprarenal 21 
bare-metal stent, and engaging the polymer to be delivered expanding the stent graft main 22 
body rings and adapting to the aortic neck. The iliac rings along the main body provide 23 
support for both limbs. The extra-support guidewire was partially retracted during polymer 24 
delivering. Contralateral gate was engaged during polymerization time. Iliac limbs were 25 
subsequently deployed (12x120mm in both sides) above the iliac bifurcations. After 26 
ballooning of the docking zones and the distal iliac landing zones, a completion 27 
angiography showed the presence of an early, high-flow type Ia endoleak. Therefore, 28 
proximal rings were dilated by 40mm compliant balloon catheter (Coda, Cook Inc, 29 
Bloomington, IN, USA). Completion angiography demonstrated a significant reduction of 30 
the proximal endoleak. At that time, no additional procedure was performed. Access 31 
haemostasis was achieved by percutaneous closure devices (Proglide, Abbott, Abbott 32 
Park, IL, USA). 33 
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Postoperative course was uneventful even in presence of type Ia endoleak 1 
confirmed by DUS and CTA. Partial infolding of the two sealing rings was clearly evident at 2 
postoperative CTA (Fig.2). Patient refused any further procedure and was then discharged 3 
on 4th postoperative days in good general condition. 4 
After 1 month, scheduled DUS control showed the absence of any endoleak with 5 
complete thrombosis of the aneurismal sac. 6 
A further CTA performed at 3 months from EVAR procedure, confirmed the 7 
aneurysm exclusion with initial shrinkage of the sac (maximum diameter 43mm). As 8 
showed in figure 3, the two sealing rings appeared much more expanded respect to the 9 
first CTA performed in 3rd post-operative day. 10 
 11 
 12 
 13 
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DISCUSSION 1 
Since first implantation, EVAR treatment aimed to prevent AAA rupture and 2 
consequent patient’s death11. Therefore, an perfused aneurismal sac after a completion 3 
angiography is considered as a technical failure11. The most significant cause of persistent 4 
sac pressurization after EVAR and aneurysms enlargement until rupture is represented by 5 
type Ia endoleak12. Although rare, with an estimated intraprocedural incidence of 3.3%, 6 
type Ia endoleak could lead to devastating results13.  For those reasons, an aggressive 7 
management of intraoperative type Ia endoleak is supported by current evidence14, 8 
although not universally accepted15,16,17.  9 
Several adjunctive procedures have been proposed to correct type Ia endoleak 10 
including proximal stent graft extension, insertion of a Palmaz stent (Cordis, Miami Lakes, 11 
FL, USA), and coil embolization12. Recently, fenestrated stent graft18, chimney technique19, 12 
and EndoAnchors (Aptus Endosystems Inc, Sunnyvale, Calif)20 have been proposed. 13 
Conversion to open repair is still considered the last chance procedure to solve a type I 14 
endoleak21. 15 
Despite this general agreement and the great variability of proposed solutions, type 16 
Ia endoleaks are not treated in all published EVAR experience. Bastos-Gonçalves et al 17 
reported spontaneous sealing of all but one type Ia endoleaks that developed after stent 18 
graft placement and ballooning of the sealing zones in a cohort of 15 patients15. Another 19 
study by Terramani et al on a series of 10 patients reported spontaneous resolution of type 20 
I endoleaks in 7 of them21. Recently, Millen et al in a series of persisting type Ia endoleaks 21 
after EVAR procedures reported that 94% of patients demonstrated spontaneous 22 
resolution on the first surveillance CTA. In their experience, recurrence of the endoleak is 23 
not reported, and no aneurysm-related deaths occurred (median follow-up of 27 months)17. 24 
Nonetheless, despite those encouraging results Bastos-Gonclaves et al reported 25 
that at a median follow-up of more than 3 years, there was a higher recurrence of type Ia 26 
endoleaks, migration, secondary intervention, and conversion to open repair compared 27 
with a control group, although without statistically significant differences15. 28 
Notably, Ovation stentgraft was never implanted in those series. This stentgraft 29 
represents a new concept of sealing by nonexpansive circumferential apposition of 30 
polymer-filled rings to aortic wall, and creates no outward force at the infrarenal aortic 31 
level. Ovation stentgraft’s sealing mechanism is completely different from Nitinol based 32 
stentgrafts. It’s therefore possible that Authors’ conclusions15,17,21 could be considered 33 
unreliable for a different, not Nitinol depending sealing. 34 
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Occurrence of type Ia endoleak after Ovation stentgraft implantation is rare, 1 
particularly in highly selected patients. Mehta, in the pivotal study on 161 patients, 2 
reported no early case and only 2 cases during a one-year follow-up9. Those two patients 3 
and all other reported in published series have been treated by open conversion or redo 4 
endovascular procedures5,6,7,8,9.  5 
In our case the early onset of a type Ia endoleak was due to infolding of the two 6 
sealing rings of the graft, as showed in postoperative CTA.  7 
Our findings look very similar to the case recently reported by Gandini et al after 7 8 
months from index EVAR procedure5. So the infolding of the polymer ring was the primary 9 
cause of both the endoleaks. They explained the appearance of the late endoleak as 10 
consequence of the continuous and prolonged stress on the aortic wall, resulting in aortic 11 
cleft and loss of sealing5. Such considerations could not be applied to our case, due the 12 
fact that the endoleak was evident since the completion angiography.  13 
Moulakakis et al reported that an excessive oversizing (more frequently with the use 14 
of the largest main-body available) in specific anatomical situation (conical and heavily 15 
calcified proximal neck) could lead to device failure22. Nonetheless, in our case a 34mm 16 
main-body was implanted in a conical, not calcified neck, ranging in diameter between 28 17 
and 30.7mm, and the estimated oversizing of 21% was very close to the value 18 
recommended by the manufactory (15-20%).  19 
Our failure happened in the very early period and in a suitable aortic neck in 20 
contrast with those experiences5,22, so other causes should be identified to explain 21 
immediate ring infolding. Our empiric idea was that in some way a packaging defect could 22 
have conditioned an abnormal and insufficient distension of the two sealing rings, leading 23 
to material failure. Of course, as the graft was not explanted we have not conclusive 24 
evidences. From a speculative point of view, to send the delivery system to Trivascular for 25 
a deep analysis could have been a valuable tool to better address the possible causes of 26 
the device failure.  27 
According with existing literature5,6,7,8, we proposed a new endovascular approach 28 
to the patient but he refused our strategy, deciding to wait the scheduled 30-day follow-up 29 
prior of any further decision. 30 
 Despite this occurrence, after 30 days, type Ia disappeared at DUS and sealing 31 
was correctly achieved. The 3-month follow-up CTA confirmed the sealing of the sac, and 32 
showed the sealing rings to be much more distended compared to the first postoperative 33 
CTA, yet not completely expanded. We could speculate that in some ways the polymer of 34 
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the sealing rings has undergone a further process of expansion associated with a 1 
simultaneous aortic wall retraction ensuring a good proximal sealing, even in absence of 2 
reintervention. 3 
In conclusion, we could not reach conclusive evidences from the analysis of an 4 
anecdotal case, but it could be interesting to evaluate the effect of an initial less 5 
aggressive approach for tipe Ia endoleak after Ovation stentgraft deployment in larger 6 
series. 7 
 8 
 9 
FIGURES LEGEND 10 
 11 
 12 
Figure 1: preoperative CTA. A: MPR reconstruction of the short, conic proximal 13 
neck of the aneurysm; B: diameter of the aorta at infrarenal (IR) level 19.6mm; C: IR+13 14 
28mm; D: IR+16 30.7mm. 15 
 16 
 17 
Figure 2: pre discharge CTA. A: 3D volume rendering reconstruction whit evidence 18 
of a type Ia endoleak; B: correctly deployment of the Ovation endograft in the infrarenal 19 
level; C: partial infolding of the first sealing ring; D: partial infolding of the second sealing 20 
ring  21 
 22 
 23 
Figure 3: CTA after 3 months. A: 3D Volume rendering reconstruction whit 24 
evidence of spontaneous resolution of the type Ia endoleak; B: absence of the migration of 25 
the endograft in the infrarenal level; C, D partial expansion of the infolding of the both 26 
sealing rings.  27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
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